硫胺组修改对塞莱科西布的影响:矩阵金属蛋白酶交互性UTX-121衍生物的分子特征
Kazuto Ohkura1, Atsushi Tabata2, Yoshihiro Uto2
1Graduate School of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan; kohkura@suzuka-u.ac.jp.
Anticancer research
|August 1, 2025
概括
一种新的UTX-121衍生物a2通过强烈抑制矩阵甲蛋白酶-2 (MMP-2) 来证明增强抗瘤活性. 这种衍生品对开发针对MMP-2的新抗癌疗法充满希望.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 矩阵金属蛋白酶 (MMPs) 在细胞外矩阵 (ECM) 降解中起着至关重要的作用.
- 抑制MMP是一种新型抗瘤疗法的潜在策略.
- 合成了UTX-121衍生物,以探索它们对MMP活性的影响.
研究的目的:
- 评估UTX-121衍生物的抗瘤活性.
- 评估UTX-121衍生物对MMPs的抑制作用.
- 研究UTX-121衍生物和MMP之间的分子相互作用.
主要方法:
- 用UTX-121衍生物对待HT-1080细胞,并通过WST-8测定测量抗瘤活性.
- 采用凝血图来检查对MMPs的抑制作用.
- 使用CAChe-Conflex和Molegro虚拟对接器进行了对形和分子对接分析.
主要成果:
- 与母化合物UTX-121相比,UTX-121衍生物a2表现出优越的抗瘤活性.
- 衍生物a2显示MMP-2的增强抑制,由减少带强度在zymography中证明.
- 分子对接揭示了a2和MMP-2 (Tyr366) 之间的特定键相互作用.
结论:
- UTX-121衍生物a2显示出强大的MMP-2抑制活性.
- 增强的活性归因于与MMP-2的特定结相互作用.
- 衍生物a2是开发新型MMP-2向抗癌剂的有前途的化合物.
相关概念视频
Drug Metabolism: Phase II Reactions
4.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.1K
Role of Matrix Metalloproteases in Degradation of ECM
2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K
Drugs for Treatment of Ulcerative Colitis in IBD
238
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
238
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K


